CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study

Yu Ri Kim, Soo-Jeong Kim, Hye Sun Lee, Soyoung Jeon, Hyunsoo Cho, Haerim Chung, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jin Seok Kim

Cancer Research and Treatment. 2022;54(2):613-620. Published online 2021 August 5 DOI: https://doi.org/10.4143/crt.2021.270

Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study

Yu Ri Kim, Soo-Jeong Kim, Hye Sun Lee, Soyoung Jeon, Hyunsoo Cho, Haerim Chung, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jin Seok Kim

Cancer Research and Treatment. 2022;54(2):613-620

Link1

Link2 Link3

Progression Free Survival at 24 Months in Patients with Diffuse Large B-Cell Lymphoma, an Argentinian Retrospective Cohort Study

Fernando Warley, Nancy Cristaldo, Giuliana Colucci, Victoria Otero

Clinical Lymphoma Myeloma and Leukemia. 2018;18:S290-S291

Link1 Link2

EVENT FREE SURVIVAL AT 12 MONTHS AND 24 MONTHS AS PREDICTORS FOR OUTCOME OF SYSTEMIC PERIPHERAL T CELL LYMPHOMA: ANALYSIS OF NATIONWIDE THAI LYMPHOMA STUDY GROUP

K. Wudhikarn, U. Bunworasate, J. Julamanee, A. Lekhakula, S. Ekwattanakit, A. Khuhapinant, L. Norasetthada, W. Nawarawong, C. Laoruangroj, T. Numbenjapon, P. Niparuck, S. Chancharunee, N. Kanitsap, S. Wongkhantee, N. Makruasi, P. Wong, C. Sirijerachai, K. Chansung, T. Suwanban, P. Praditsuktavorn, T. Intragumtornchai

Hematological Oncology. 2019;37:277-278

Link1 Link2

Age is the most important predictor of survival in diffuse large B‐cell lymphoma patients achieving event‐free survival at 24 months: a Swedish population‐based study

Amal Abu Sabaa, Charlott Mörth, Sverker Hasselblom, Gustaf Hedström, Max Flogegård, Mimmi Stern, Per‐Ola Andersson, Ingrid Glimelius, Gunilla Enblad

British Journal of Haematology. 2021;193(5):906-914

Link1 Link2 Link3

Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma

Kitsada Wudhikarn, Udomsak Bunworasate, Jakrawadee Julamanee, Arnuparp Lekhakula, Supachai Ekwattanakit, Archrob Khuhapinant, Pimjai Niparuck, Suporn Chuncharunee, Tontanai Numbenjapon, Kannadit Prayongratana, Nonglak Kanitsap, Somchai Wongkhantee, Nisa Makruasri, Peerapon Wong, Lalita Norasetthada, Weerasak Nawarawong, Chittima Sirijerachai, Kanchana Chansung, Tawatchai Suwanban, Pannee Praditsuktavorn, Tanin Intragumtornchai,

Hematological Oncology. 2019;37(5):578-585

Link1 Link2 Link3 Link4

Poster: MCL-027 Prognostic Role of Event-Free Survival at 24 Months (EFS24) in Newly Diagnosed Mantle Cell Lymphoma (MCL)

Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Thomas E. Witzig, Thomas M. Habermann, James R. Cerhan, Grzegorz S. Nowakowski

Clinical Lymphoma Myeloma and Leukemia. 2022;22:S175

Link1 Link2

MCL-027 Prognostic Role of Event-free Survival at 24 Months (EFS24) in Newly Diagnosed Mantle Cell Lymphoma (MCL)

Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Thomas E. Witzig, Thomas M. Habermann, James R. Cerhan, Grzegorz S. Nowakowski

Clinical Lymphoma Myeloma and Leukemia. 2022;22:S394

Link1 Link2

A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

Sung Han Kim, Sohee Kim, Jungnam Joo, Ho Kyung Seo, Jae Young Joung, Kang Hyun Lee, Jinsoo Chung

BMC Cancer. 2016;16(1):

Link1

Link2 Link3 Link4

Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group

Mariano Provencio, Ana Royuela, María Torrente, Marina Pollán, José Gómez-Codina, Pilar Sabín, Marta Llanos, Josep Gumá, Cristina Quero, Ana Blasco, David Aguiar, Francisco Ramón García-Arroyo, Javier Lavernia, Natividad Martínez, Manuel Morales, Álvaro Saenz-Cusi, Delvys Rodríguez, Virginia Calvo, Luis de la Cruz-Merino, Miguel Ángel de la Cruz, Antonio Rueda,

Cancer. 2017;123(19):3709-3716

Link1 Link2

High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study

Mari Morita-Fujita, Daisuke Katoh, Yoshimitsu Shimomura, Takayuki Ishikawa

Clinical Lymphoma Myeloma and Leukemia. 2019;19(7):e337-e342

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.